Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Confirmation Watch: Gottlieb Likely To Face Questions About Approval Standards, Ties To Industry

Executive Summary

Top HELP Committee Democrat Patty Murray tweeted concerns about Gottlieb's positions on the "gold standard" of FDA approval; Pubic Citizen's Michael Carome ultimately thinks Gottlieb will be approved.


Related Content

Q&A: Mark McClellan Discusses Gottlieb, Cures And More
Gottlieb At FDA: Industry Will Look For User-Fee Deal Support, Restrained Regulations
Possible Trump FDA Commish Candidate Favors (Much) Lighter Touch
Califf’s Confirmation Fall-Out: Should Sponsors Worry About Research Contracts?
FDA Can Help On Drug Prices – Except When It Can't, Califf Says
Renal Denervation Researcher Argues Sham Control Is Ethically Necessary


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst